Australia seems poised to gain access to a groundbreaking therapy for obesity: Retatrutide. The dual molecule – working on both GLP-1 and GIP receptors – demonstrates significant outcomes in global trials, https://retatrutide-australia-we481395.cosmicwiki.com/user